MeSH term
Frequency | Condition_Probility | Animals | 28 | 0.0 |
Binding Sites | 3 | 0.0 |
*Cell Cycle Proteins | 27 | 2.0 |
Cells, Cultured | 5 | 0.0 |
DNA Primers | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
Humans | 45 | 0.0 |
Interleukin-2/genetics | 2 | 2.0 |
Mice | 17 | 0.0 |
Mice, Knockout | 4 | 0.0 |
*Nuclear Proteins | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 34 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 21 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
src Homology Domains | 2 | 0.0 |
*Adaptor Proteins, Signal Transducing | 2 | 0.0 |
Cell Adhesion/physiology | 2 | 0.0 |
Integrins/*physiology | 2 | 2.0 |
Receptors, Antigen, T-Cell/*physiology | 4 | 2.0 |
Signal Transduction/*physiology | 3 | 0.0 |
Cytoskeleton/*metabolism | 4 | 3.0 |
Mutation | 5 | 0.0 |
Platelet Adhesiveness/drug effects | 2 | 4.0 |
Platelet Glycoprotein GPIIb-IIIa Complex/*metabolism | 2 | 6.0 |
Protein Binding | 6 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Phosphorylation | 17 | 0.0 |
COS Cells | 5 | 0.0 |
Enzyme Induction | 2 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
Protein Transport | 2 | 0.0 |
Signal Transduction | 7 | 0.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 3 | 0.0 |
Antibodies, Monoclonal/pharmacology | 2 | 0.0 |
Gene Expression Regulation/immunology | 2 | 1.0 |
*Genes, fos | 2 | 3.0 |
Jurkat Cells | 14 | 1.0 |
Lymphocyte Activation | 3 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 4 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 5 | 0.0 |
Receptors, Antigen, T-Cell/*metabolism | 2 | 1.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Transfection | 10 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 3 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Actins/*metabolism | 2 | 0.0 |
Isoenzymes/metabolism | 2 | 0.0 |
Membrane Microdomains/*metabolism | 2 | 4.0 |
Mutagenesis | 2 | 0.0 |
Protein Kinase C/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/genetics/metabolism/*physiology | 2 | 12.0 |
3T3 Cells | 2 | 0.0 |
Cell Line | 6 | 0.0 |
Enzyme Activation | 6 | 0.0 |
Oncogene Proteins/chemistry/genetics/*physiology | 2 | 40.0 |
Precipitin Tests | 3 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Time Factors | 2 | 0.0 |
rac GTP-Binding Proteins/metabolism | 4 | 6.0 |
rhoA GTP-Binding Protein/metabolism | 2 | 2.0 |
Gene Expression | 2 | 0.0 |
Isoenzymes/*metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinase 8 | 2 | 2.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
Female | 3 | 0.0 |
Ligands | 2 | 0.0 |
rac1 GTP-Binding Protein/metabolism | 3 | 3.0 |
Base Sequence | 2 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 3 | 0.0 |
*Lymphocyte Activation | 2 | 0.0 |
T-Lymphocytes/*immunology | 7 | 0.0 |
Transcription Factors/metabolism | 4 | 0.0 |
CHO Cells | 3 | 0.0 |
Hamsters | 4 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 4 | 0.0 |
Signal Transduction/*immunology | 3 | 0.0 |
Actins/metabolism | 4 | 0.0 |
Epidermal Growth Factor/pharmacology | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Platelet-Derived Growth Factor/pharmacology | 2 | 1.0 |
Molecular Sequence Data | 2 | 0.0 |
Proto-Oncogene Proteins/chemistry/*metabolism | 2 | 3.0 |
Receptors, Antigen, T-Cell/metabolism | 2 | 1.0 |
*Signal Transduction | 2 | 0.0 |
Tyrosine/metabolism | 5 | 0.0 |
Phospholipase C/physiology | 2 | 7.0 |
Proto-Oncogene Proteins/genetics/*physiology | 2 | 2.0 |
Comparative Study | 2 | 0.0 |
Lymphocyte Activation/immunology | 2 | 0.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 4 | 1.0 |
Proto-Oncogene Proteins/immunology | 2 | 14.0 |
Models, Immunological | 2 | 0.0 |
cdc42 GTP-Binding Protein/metabolism | 2 | 1.0 |
Receptors, Immunologic/genetics/metabolism | 2 | 10.0 |
Immunoblotting | 2 | 0.0 |
Cytoskeleton/metabolism | 2 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Male | 2 | 0.0 |
Phospholipase C/metabolism | 2 | 0.0 |
